[HTML][HTML] A comprehensive review of mechanical circulatory support devices

V Atti, MA Narayanan, B Patel, S Balla… - Heart …, 2022 - ncbi.nlm.nih.gov
Abstract Treatment strategies to combat cardiogenic shock (CS) have remained stagnant
over the past decade. Mortality rates among patients who suffer CS after acute myocardial …

Twelfth interagency registry for mechanically assisted circulatory support report: readmissions after left ventricular assist device

P Shah, M Yuzefpolskaya, GW Hickey… - The Annals of thoracic …, 2022 - Elsevier
The twelfth annual report from The Society of Thoracic Surgeons (STS) Interagency Registry
for Mechanically Assisted Circulatory Support (Intermacs) highlights outcomes for 26 688 …

HVAD to HeartMate 3 left ventricular assist device exchange: best practices recommendations

CT Salerno, C Hayward, S Hall… - European Journal of …, 2022 - academic.oup.com
The HeartWare HVAD System (Medtronic) is a durable left ventricular assist device (LVAD)
approved for bridge to transplant indication in 2012 and destination therapy indication in …

Dietary copper intake and risk of stroke in adults: a case-control study based on national health and nutrition examination survey 2013–2018

L Yang, X Chen, H Cheng, L Zhang - Nutrients, 2022 - mdpi.com
The association between dietary copper intake and the risk of stroke is unknown. We
included a total of 10,550 participants from the National Health and Nutrition Examination …

Dynamic risk estimation of adverse events in ambulatory LVAD patients: a MOMENTUM 3 analysis

P Shah, G Sayer, SS Sinha, MK Kanwar, JA Cowger… - Heart Failure, 2024 - jacc.org
Background Hemocompatibility-related adverse events affect patients after left ventricular
assist device (LVAD) implantation but are hard to predict. Objectives Dynamic risk modeling …

HVAD to HeartMate 3 device exchange: a Society of Thoracic Surgeons Intermacs analysis

R Cogswell, RS Cantor, E Vorovich, A Kilic… - The Annals of thoracic …, 2022 - Elsevier
Abstract Background On June 3, 2021 Medtronic, Inc announced discontinuation of the
HVAD left ventricular assist device. The purpose of this analysis was to provide summary …

[HTML][HTML] The year in cardiovascular medicine 2021: heart failure and cardiomyopathies

J Bauersachs, RA de Boer, JA Lindenfeld… - Cardiologia …, 2022 - hrcak.srce.hr
Sažetak In the year 2021, the universal definition and classification of heart failure (HF) was
published that defines HF as a clinical syndrome with symptoms and/or signs caused by a …

Stroke and mechanical circulatory support in adults

DJ Bae, JZ Willey, C Ibeh, M Yuzefpolskaya… - Current Cardiology …, 2023 - Springer
Abstract Purpose of the Review Short-term and durable mechanical circulatory support
(MCS) devices represent life-saving interventions for patients with cardiogenic shock and …

[HTML][HTML] Association between serum copper levels and stroke in the general population: A nationally representative study

Z Chen, X Liu, Y Wu, X Qi, Q Ling, Z Wu, Y Shi… - Journal of Stroke and …, 2024 - Elsevier
Objectives The objective was to explore the association between serum copper levels and
the prevalence of stroke. Methods Data were obtained from 3 consecutive National Health …

Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices

L Numan, D Zimpfer, OIB Zadok, E Aarts… - ESC heart …, 2023 - Wiley Online Library
Aims Since the withdrawal of HeartWare (HVAD) from the global market, there is an ongoing
discussion if and which patients require prophylactically exchange for a HeartMate 3 (HM3) …